Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Local Knowledge Coupled With Extensive Partnerships Required For Asia Success: BioMedical Asia 2008

This article was originally published in PharmAsia News

Executive Summary

SINGAPORE - Recreating existing business models in Asia will likely not be successful in the long run, panelists concurred at the Biomedical Asia 2008 conference held in Singapore, April 15-17. In fact, what may make or break a company will be its capacity to collaborate in a system of multiple vendors in an extreme outsourcing environment

You may also be interested in...



Pharma Executives Say Partnering Key To Success In Japan: Tokyo Conference (Part 1 of 2)

TOKYO - Several pharmaceutical company executives who gathered at the "Moving Quickly To Clinical POC" R&D conference in Tokyo May 9 to May 11 discussed what to look for when partnering in Japan

Pharma Executives Say Partnering Key To Success In Japan: Tokyo Conference (Part 1 of 2)

TOKYO - Several pharmaceutical company executives who gathered at the "Moving Quickly To Clinical POC" R&D conference in Tokyo May 9 to May 11 discussed what to look for when partnering in Japan

Lack Of VC Industry In Asia Means Public Institutions Need To Step In and Take On Risk

SINGAPORE - Public institutions will need to step in and narrow the sizable gap between early research and commercialization in much of Asia, experts told an April 16 panel at the BioMedical Asia conference in Singapore

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068271

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel